Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1941 2
1945 1
1946 6
1947 5
1948 10
1949 6
1950 9
1951 9
1952 4
1953 6
1954 2
1955 3
1957 2
1958 4
1959 8
1960 3
1961 3
1962 4
1963 3
1964 5
1965 3
1966 3
1967 6
1968 8
1969 7
1970 6
1971 15
1972 9
1973 11
1974 12
1975 9
1976 13
1977 10
1978 14
1979 17
1980 10
1981 8
1982 14
1983 12
1984 24
1985 15
1986 18
1987 13
1988 20
1989 25
1990 21
1991 37
1992 36
1993 51
1994 31
1995 26
1996 24
1997 23
1998 35
1999 28
2000 18
2001 27
2002 20
2003 32
2004 35
2005 50
2006 35
2007 39
2008 39
2009 30
2010 27
2011 39
2012 29
2013 37
2014 33
2015 32
2016 42
2017 47
2018 41
2019 52
2020 47
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

1,386 results
Results by year
Filters applied: . Clear all
Page 1
Mumps.
Hviid A, Rubin S, Mühlemann K. Hviid A, et al. Among authors: rubin s. Lancet. 2008 Mar 15;371(9616):932-44. doi: 10.1016/S0140-6736(08)60419-5. Lancet. 2008. PMID: 18342688 Review.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
Coleman RL, Spirtos NM, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim JW, Park SY, Kim BG, Nam JH, Fujiwara K, Walker JL, Casey AC, Alvarez Secord A, Rubin S, Chan JK, DiSilvestro P, Davidson SA, Cohn DE, Tewari KS, Basen-Engquist K, Huang HQ, Brady MF, Mannel RS. Coleman RL, et al. Among authors: rubin s. N Engl J Med. 2019 Nov 14;381(20):1929-1939. doi: 10.1056/NEJMoa1902626. N Engl J Med. 2019. PMID: 31722153 Free PMC article. Clinical Trial.
Integrating Old and New Paradigms of G1/S Control.
Rubin SM, Sage J, Skotheim JM. Rubin SM, et al. Mol Cell. 2020 Oct 15;80(2):183-192. doi: 10.1016/j.molcel.2020.08.020. Epub 2020 Sep 17. Mol Cell. 2020. PMID: 32946743 Review.
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Coleman RL, et al. Among authors: rubin sc. Lancet Oncol. 2017 Jun;18(6):779-791. doi: 10.1016/S1470-2045(17)30279-6. Epub 2017 Apr 21. Lancet Oncol. 2017. PMID: 28438473 Free PMC article. Clinical Trial.
Molecular mechanisms underlying RB protein function.
Dick FA, Rubin SM. Dick FA, et al. Among authors: rubin sm. Nat Rev Mol Cell Biol. 2013 May;14(5):297-306. doi: 10.1038/nrm3567. Epub 2013 Apr 18. Nat Rev Mol Cell Biol. 2013. PMID: 23594950 Free PMC article. Review.
Improved overall survival in melanoma with combined dabrafenib and trametinib.
Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L, Chiarion-Sileni V, Drucis K, Krajsova I, Hauschild A, Lorigan P, Wolter P, Long GV, Flaherty K, Nathan P, Ribas A, Martin AM, Sun P, Crist W, Legos J, Rubin SD, Little SM, Schadendorf D. Robert C, et al. Among authors: rubin sd. N Engl J Med. 2015 Jan 1;372(1):30-9. doi: 10.1056/NEJMoa1412690. Epub 2014 Nov 16. N Engl J Med. 2015. PMID: 25399551 Free article. Clinical Trial.
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.
Lambert J, Pautas C, Terré C, Raffoux E, Turlure P, Caillot D, Legrand O, Thomas X, Gardin C, Gogat-Marchant K, Rubin SD, Benner RJ, Bousset P, Preudhomme C, Chevret S, Dombret H, Castaigne S. Lambert J, et al. Among authors: rubin sd. Haematologica. 2019 Jan;104(1):113-119. doi: 10.3324/haematol.2018.188888. Epub 2018 Aug 3. Haematologica. 2019. PMID: 30076173 Free PMC article. Clinical Trial.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR. Goss PE, et al. Among authors: rubin s. N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5. N Engl J Med. 2016. PMID: 27264120 Free PMC article. Clinical Trial.
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D. Geyer CE, et al. Among authors: rubin sd. N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320. N Engl J Med. 2006. PMID: 17192538 Free article. Clinical Trial.
1,386 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page